Physician

Ross B Chod, M.D.

According to 2025 Medicare claims, Ross Chod, M.D. (NPI: 1801158548) practices ophthalmology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Arapahoe, CO. This provider's primary affiliated billing organization is RSC AURORA, PLLC (NPI: 1023755626; TIN: 88-2033975) and primary practice location at 80012-4540.

Chod's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 697 traditional Medicare patients, billed 96,500 HCPCS/CPT codes, and received $2,624,321 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 327 prescription claims across 144 beneficiaries totaling $11,439 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 47 records totaling $23,972. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,747 to $2,624,321. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $27,972 to $11,439. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2017 Medicare payment: $1,747 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $13,668 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $131,052 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $281,139 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $411,004 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $675,682 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,142,468 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,624,321 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20173440$1,747
201857147$13,668
20191561,549$131,052
20201782,061$281,139
20212392,828$411,004
20223563,895$675,682
202340961,904$1,142,468
202469796,500$2,624,321

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$43K$85K2015 Drug cost: $27,972 (USD; Tot_Drug_Cst)2016 Drug cost: $85,147 (USD; Tot_Drug_Cst)2017 Drug cost: $49,577 (USD; Tot_Drug_Cst)2018 Drug cost: $19,772 (USD; Tot_Drug_Cst)2019 Drug cost: $8,574 (USD; Tot_Drug_Cst)2020 Drug cost: $12,409 (USD; Tot_Drug_Cst)2021 Drug cost: $11,773 (USD; Tot_Drug_Cst)2022 Drug cost: $14,772 (USD; Tot_Drug_Cst)2023 Drug cost: $14,690 (USD; Tot_Drug_Cst)2024 Drug cost: $11,439 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015110255$27,972
20162461,048$85,147
2017176754$49,577
201875325$19,772
201941172$8,574
202040208$12,409
202151242$11,773
2022118331$14,772
2023124337$14,690
2024144327$11,439

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3221,213$94
92014Established patient complete exam of visual system350565$93
92012Established patient problem focused exam of visual system290994$71
92134Imaging of retina6911,946$32
92201Extended exam of the back part of the eye with retinal drawing429653$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1154,246$5,996
OfloxacinOfloxacin872,999$1,285
Ketorolac TromethamineKetorolac Tromethamine17504$572
Brimonidine TartrateBrimonidine Tartrate13815$540
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat231,834$297

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.46$4,290EyePoint Pharmaceuticals US, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$19,681EyePoint Pharmaceuticals US, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ross B. Chod, M.D.?

Tedicare shows public-source Medicare data for Ross B. Chod, M.D. (NPI 1801158548), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ross B. Chod, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ross B. Chod, M.D.?

Ross B. Chod, M.D. is linked to RSC AURORA, PLLC (billing NPI 1023755626) in the available physician profile data.

Does Ross B. Chod, M.D. have Open Payments data?

Ross B. Chod, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.